Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-06-09 09:05:14 |
Versijas komentārs | |
Teksts |
Recording of the First Quarter 2016 Investor Conference Webinar
On June 8 AS „Olainfarm” organized
its Investor Conference Online Webinar. During the webinar the
member of the management board of AS „Olainfarm” Salvis Lapiņš
analyzed the financial results of first quarter 2016 and informed
about other recent activities within the company.
During the presentation Salvis
Lapiņš noted that Olainfarm has started working on acquisition idea
in Belarus, while there are no serious acquisition plans in Russia
at the moment. As previously announced, there are two more
acquisition ideas that are currently in advance state. During the
webinar Salvis Lapiņš also elaborated on profit prognoses for 2016
and explained that decrease in profit prognoses are associated with
Ukrainian provisions in amount of 4.5 M EUR.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/OLF_Q1_2016_rec,
and the
presentation, demonstrated during the webinar, is available in the
previously published company’s announcement: http://ej.uz/OLF_Q1_2016_PDF_LV.
Olainfarm thanks all participants,
who joined the webinar, and encourages everybody to follow
company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information prepared by: |
Pielikumi |
|